BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

445 related articles for article (PubMed ID: 31241817)

  • 1. Role of chronic cannabis use: Cyclic vomiting syndrome vs cannabinoid hyperemesis syndrome.
    Venkatesan T; Levinthal DJ; Li BUK; Tarbell SE; Adams KA; Issenman RM; Sarosiek I; Jaradeh SS; Sharaf RN; Sultan S; Stave CD; Monte AA; Hasler WL
    Neurogastroenterol Motil; 2019 Jun; 31 Suppl 2(Suppl 2):e13606. PubMed ID: 31241817
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cannabinoid hyperemesis and the cyclic vomiting syndrome in adults: recognition, diagnosis, acute and long-term treatment.
    Blumentrath CG; Dohrmann B; Ewald N
    Ger Med Sci; 2017; 15():Doc06. PubMed ID: 28400711
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Haloperidol for treatment of cannabinoid hyperemesis syndrome.
    Hickey JL; Witsil JC; Mycyk MB
    Am J Emerg Med; 2013 Jun; 31(6):1003.e5-6. PubMed ID: 23583118
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Emergency Department Treatment of Cannabinoid Hyperemesis Syndrome: A Review.
    Khattar N; Routsolias JC
    Am J Ther; 2018; 25(3):e357-e361. PubMed ID: 28953512
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The utility of droperidol in the treatment of cannabinoid hyperemesis syndrome.
    Lee C; Greene SL; Wong A
    Clin Toxicol (Phila); 2019 Sep; 57(9):773-777. PubMed ID: 30729854
    [No Abstract]   [Full Text] [Related]  

  • 6. Cannabinoid hyperemesis syndrome.
    Galli JA; Sawaya RA; Friedenberg FK
    Curr Drug Abuse Rev; 2011 Dec; 4(4):241-9. PubMed ID: 22150623
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patterns of Cannabis Use in Patients With Cyclic Vomiting Syndrome.
    Venkatesan T; Hillard CJ; Rein L; Banerjee A; Lisdahl K
    Clin Gastroenterol Hepatol; 2020 May; 18(5):1082-1090.e2. PubMed ID: 31352091
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cannabinoid hyperemesis syndrome: Clinical trajectories and patterns of use three months following a visit to the emergency department.
    Wightman RS; Metrik J; Lin TR; Collins AB; Beaudoin FL
    Acad Emerg Med; 2024 May; 31(5):463-470. PubMed ID: 37387520
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endocannabinoid system and cannabis hyperemesis syndrome: a narrative update.
    Perisetti A; Goyal H
    Eur J Gastroenterol Hepatol; 2022 Jan; 34(1):1-8. PubMed ID: 33208685
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cannabinoid Hyperemesis Syndrome: Diagnosis, Pathophysiology, and Treatment-a Systematic Review.
    Sorensen CJ; DeSanto K; Borgelt L; Phillips KT; Monte AA
    J Med Toxicol; 2017 Mar; 13(1):71-87. PubMed ID: 28000146
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cannabinoid hyperemesis syndrome: a review of the literature.
    Deceuninck E; Jacques D
    Psychiatr Danub; 2019 Sep; 31(Suppl 3):390-394. PubMed ID: 31488758
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cannabinoid hyperemesis syndrome.
    Parekh JD; Wozniak SE; Khan K; Dutta SK
    BMJ Case Rep; 2016 Jan; 2016():. PubMed ID: 26791124
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is haloperidol the wonder drug for cannabinoid hyperemesis syndrome?
    Inayat F; Virk HU; Ullah W; Hussain Q
    BMJ Case Rep; 2017 Jan; 2017():. PubMed ID: 28052951
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cannabinoid hyperemesis syndrome: a case series and review of previous reports.
    Nicolson SE; Denysenko L; Mulcare JL; Vito JP; Chabon B
    Psychosomatics; 2012; 53(3):212-9. PubMed ID: 22480624
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Cannabinoid hyperemesis syndrome: A review of the literature].
    Desjardins N; Stheneur C
    Arch Pediatr; 2016 Jun; 23(6):619-23. PubMed ID: 27017363
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological management of cannabinoid hyperemesis syndrome: an update of the clinical literature.
    Burillo-Putze G; Richards JR; Rodríguez-Jiménez C; Sanchez-Agüera A
    Expert Opin Pharmacother; 2022 Apr; 23(6):693-702. PubMed ID: 35311429
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cannabinoid hyperemesis syndrome. A report of six new cases and a summary of previous reports.
    Contreras Narváez C; Mola Gilbert M; Batlle de Santiago E; Bigas Farreres J; Giné Serven E; Cañete Crespillo J
    Adicciones; 2016 Mar; 28(2):90-8. PubMed ID: 26990261
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cannabinoid Hyperemesis Syndrome: Reports of Fatal Cases.
    Nourbakhsh M; Miller A; Gofton J; Jones G; Adeagbo B
    J Forensic Sci; 2019 Jan; 64(1):270-274. PubMed ID: 29768651
    [TBL] [Abstract][Full Text] [Related]  

  • 19. "I still partly think this is bullshit": A qualitative analysis of cannabinoid hyperemesis syndrome perceptions among people with chronic cannabis use and cyclic vomiting.
    Collins AB; Beaudoin FL; Metrik J; Wightman RS
    Drug Alcohol Depend; 2023 May; 246():109853. PubMed ID: 36996524
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Running Out of Options: Rhabdomyolysis Associated with Cannabis Hyperemesis Syndrome.
    Trappey BE; Olson APJ
    J Gen Intern Med; 2017 Dec; 32(12):1407-1409. PubMed ID: 28664257
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.